The application of molecular techniques to the study of human pregnanc
y has resulted in the recognition that there is bidirectional cell tra
ffic during pregnancy. Recent studies indicate fetal progenitor cells
can persist in the maternal peripheral blood for decades after childbi
rth. Scleroderma is increased in women, has a peak incidence following
childbearing years, and has clinical similarities to chronic graft-ve
rsus-host disease that occurs after allogeneic stem cell transplantati
on. This paper explores the idea that microchimerism is involved in sc
leroderma and considers insights gained from transplantation biology i
n seeking to understand how microchimerism might contribute to the pat
hogenesis of scleroderma. Chimerism means that a body contains cell po
pulations derived from different indivduals and microchimerism low lev
els of chimerism. Although highlighted in the study of scleroderma, mi
crochimerism is also implicated in selected other autoimmune disorders
.